TOP2A promotes non-small cell lung cancer progression via LDHA-mediated glycolysis and histone lactylation
Our results indicate a new function for <i>TOP2A</i> in promoting NSCLC progression through modulating glycolysis and histone lactylation, suggesting <i>TOP2A</i> as a possible therapeutic target to treat NSCLC.
Authors
- Qiong Wu
- Feng Hu
- Weiqin Wang
- Fan Ye
Institutions
- Shanghai Jiao Tong University (CN)
- Tongren Hospital (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2025-702
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.52